Abstract:
A method of diagnosis of chronic stress in a patient, comprising: (a) determining the level of each of one or more analytes in the patient, wherein the one or more analytes are selected from VEGF, IL-8, MCP1, EGF and TSH; and (b) establishing the significance of the or each level.
Abstract:
A diagnostic method is disclosed which can be used to predict the risk of cancer in particular breast cancer. The method comprises: (i) isolating a biological sample from a patient; and (ii) detecting the presence or expression of the gene comprised within the sequence identified herein as SEQ ID No. (1), wherein the presence or expression of the gene indicates the presence of or the risk of cancer.
Abstract translation:公开了可以用于预测癌症特别是乳腺癌的风险的诊断方法。 该方法包括:(i)从患者分离生物样品; (ii)检测本文鉴定的序列中包含的基因的存在或表达,如SEQ ID No.(1),其中基因的存在或表达表示癌症的存在或癌症的风险。
Abstract:
An assay device processing instrument comprises a plurality of processing modules. A transport system transports an assay device to each processing module, the transport system being adapted to transfer the assay device from the transport system to the module to enable the transport system to transport another assay device while the first is processed by the processing module. A control system controls operation of the transport system such that each assay device is transferred between the modules in a predetermined sequence, and such that a number of assay devices can be processed in different modules simultaneously.
Abstract:
Novel haptens, which can be conjugated to form immunogens, are of formula I, II or III wherein R is a divalent alkyl, cycloalkyl or aryl group having 1 to 10 carbon atoms, and X is a functional group.
Abstract:
Novel haptens, which can be conjugated to form immunogens, are of formula I, II or III 1 wherein R is a divalent alkyl, cycloalkyl or aryl group having 1 to 10 carbon atoms, and X is a functional group.
Abstract:
A spin-trapping assay for nitric oxide, in a biological system such as whole blood, uses as the spin trap a lipid-soluble nitrobenzene compound such as 2,6-dimethylnitrosobenzene.
Abstract:
A biochip deposition system and method. The system comprises a deposit mechanism for depositing organic material in spots on a substrate; and a viewing system for detecting the spots on the substrate during a deposit operation and before the spots have dried, for determining if the spots have been correctly deposited, and if not, for generating a suitable output signal. The viewing system includes an illumination device for illuminating deposited spots at a relatively low angle relative to the substrate.